Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Joanne Lee, Susan Swee-Shan Hue, Stephanie Q Ko, Soo Yong Tan, Xin Liu, Louis-Pierre Girard, Esther Hian Li Chan, Sanjay De Mel, Anand Jeyasekharan, Yen Lin Chee, Liang Piu Koh & Li Mei Poon. (2019) Clinical impact of the cell-of-origin classification based on immunohistochemistry criteria and Lymph2Cx of diffuse large B-Cell lymphoma patients in a South-east Asian population: a single center experience and review of the literature. Expert Review of Hematology 12:12, pages 1095-1105.
Read now
Read now
R. Andrew Harkins, Andres Chang, Sharvil P. Patel, Michelle J. Lee, Jordan S. Goldstein, Selin Merdan, Christopher R. Flowers & Jean L. Koff. (2019) Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma. Expert Review of Hematology 12:11, pages 959-973.
Read now
Read now
Baochai Lin, Cuie Chen, Yan Qian & Jianhua Feng. (2015) Prognostic role of peripheral blood lymphocyte/monocyte ratio at diagnosis in diffuse large B-cell lymphoma: a meta-analysis. Leukemia & Lymphoma 56:9, pages 2563-2568.
Read now
Read now
Ibrahim H. Younos, Fuminori Abe & James E. Talmadge. (2015) Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets. Leukemia & Lymphoma 56:8, pages 2251-2263.
Read now
Read now
Gregory P Kaufman, Kay M Ristow, Svetomir N Markovic & Luis F Porrata. (2014) The absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles is not significantly impacted by the use of myeloid growth factors and predicts clinical outcomes in classical Hodgkin lymphoma regardless of their use. Blood and Lymphatic Cancer: Targets and Therapy 4, pages 39-44.
Read now
Read now
Rita Coutinho & John Gribben. (2013) Biomarkers of diffuse large B-cell lymphoma: impact on diagnosis, treatment, and prognosis. Current Biomarker Findings 3, pages 17-34.
Read now
Read now
Frank Vari & Maher K. Gandhi. (2012) Back to basics: the complete blood cell count adds to the ability of immunohistochemistry in diffuse large B-cell lymphoma prognosis. Leukemia & Lymphoma 53:11, pages 2097-2098.
Read now
Read now
Articles from other publishers (35)
Barbara J. Bain. 2022. Blood Cells. Blood Cells
244
300
.
Camilla Lisanti, Debora Basile, Annamaria Parnofiello, Elisa Bertoli, Victoria Josephine Andreotti, Silvio Ken Garattini, Michele Bartoletti, Monica Cattaneo, Paola Di Nardo, Marta Bonotto, Mariaelena Casagrande, Lucia Da Ros, Marika Cinausero, Luisa Foltran, Nicoletta Pella, Angela Buonadonna, Giuseppe Aprile, Gianpiero Fasola & Fabio Puglisi. (2020) The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer. Journal of Geriatric Oncology 11:8, pages 1268-1273.
Crossref
Crossref
Pauli Vähämurto, Marjukka Pollari, Michael R. Clausen, Francesco d’Amore, Sirpa Leppä & Susanna Mannisto. (2020) Low Absolute Lymphocyte Counts in the Peripheral Blood Predict Inferior Survival and Improve the International Prognostic Index in Testicular Diffuse Large B-Cell Lymphoma. Cancers 12:7, pages 1967.
Crossref
Crossref
Eri Matsuki, Olga L. Bohn, Siraj El Jamal, Janine D. Pichardo, Andrew D. Zelenetz, Anas Younes & Julie Teruya-Feldstein. (2019) Lymphocyte-to-Monocyte Ratio May Serve as a Better Prognostic Indicator Than Tumor-associated Macrophages in DLBCL Treated With Rituximab. Applied Immunohistochemistry & Molecular Morphology 27:8, pages 572-580.
Crossref
Crossref
Yu-di Geng, Yi-ren Chen, Jin Jin, Xiao-di Wang, Shu Zhang & Deng-ju Li. (2019) Prognostic Value of D-Dimer in Patients with Diffuse Large B-cell Lymphoma: A Retrospective Study. Current Medical Science 39:2, pages 222-227.
Crossref
Crossref
Ying Tian, Yue Zhang, Wan-Qiu Zhu, Xiao-Lei Chen, He-Bing Zhou & Wen-Ming Chen. (2018) Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma. BioMed Research International 2018, pages 1-8.
Crossref
Crossref
Xiaoling Chen, Jinbiao Wu, Fanrong Zhang, Lisha Ying & Yu Chen. (2018) Prognostic Significance of Pre-Operative Monocyte-to-Lymphocyte Ratio in Lung Cancer Patients Undergoing Radical Surgery. Laboratory Medicine 49:2, pages e29-e39.
Crossref
Crossref
Simone Battella, M. Christina Cox, Raffaella La Scaleia, Arianna Di Napoli, Francesca Di Landro, Alessandra Porzia, Lavinia Franchitti, Fabrizio Mainiero, Luigi Ruco, Bruno Monarca, Angela Santoni & Gabriella Palmieri. (2017) Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy. Cancer Immunology, Immunotherapy 66:10, pages 1295-1306.
Crossref
Crossref
Shujuan Zhou, Linglong Xu, Yongyong Ma, Liyuan Tang, Yu Zhang, Yifen Shi, Lan Sun, Yi Chen, Bin Liang, Yuhong Zhou, Kang Yu & Jianping Shen. (2017) Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphoma. Oncotarget 8:12, pages 19556-19565.
Crossref
Crossref
Jeongkuk SeoWon Seog KimJin Seok KimSeok Jin KimJae Hoon LeeJun Shik HongGyeong-Won LeeSung Yong OhJi-Hyun LeeDok Hyun YoonWon-Sik LeeHyo Jung KimJae-Yong KwakHye Jin KangJae-Cheol JoYong ParkHo Sup LeeHyo-Jin KimCheolwon Suh. (2017) Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial. Blood Research 52:3, pages 200.
Crossref
Crossref
Yu-Mu Chen, Ying-Tang Fang, Chien-Hao Lai, Kun-Ming Rau, Cheng-Hua Huang, Huang-Chih Chang, Tung-Ying Chao, Chia-Cheng Tseng, Wen-Feng Fang, Chin-Chou Wang, Yung-Che Chen, Yu-Hsiu Chung, Yi-Hsi Wang, Mao-Chang Su, Shih-Feng Liu, Kuo-Tung Huang, Hung-Chen Chen, Ya-Chun Chang, Yu-Ping Chang & Meng-Chih Lin. (2016) A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases. PLOS ONE 11:12, pages e0167923.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Maria N. Dimopoulou, Maria K. Angelopoulou, Kyriaki Petevi, Gerassimos A. Pangalis, Maria Moschogiannis, Maria Dimou, George Boutsikas, Alexandros Kanellopoulos, Gabriella Gainaru, Eleni Plata, Pagona Flevari, Katerina Koutsi, Loula Papageorgiou, Vassilios Telonis, Panayiotis Tsaftaridis, Sotirios Sachanas, Xanthoula Yiakoumis, Pantelis Tsirkinidis, Nora-Athina Viniou, Marina P. Siakantaris, Eleni Variami, Marie-Christine Kyrtsonis, John Meletis, Panayiotis Panayiotidis & Kostas Konstantopoulos. (2016) Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens. The Oncologist 21:3, pages 343-353.
Crossref
Crossref
Chen Chang, Shang-Yin Wu, Yu-Wei Kang, Kun-Piao Lin, Tsai-Yun Chen, L. Jeffrey Medeiros & Kung-Chao Chang. (2015) High Levels of Regulatory T Cells in Blood Are a Poor Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma. American Journal of Clinical Pathology 144:6, pages 935-944.
Crossref
Crossref
Luis F Porrata. (2015) Adaptive cancer treatment: why I put my money on immunotherapy. The Lancet Haematology 2:10, pages e402-e403.
Crossref
Crossref
Colm Keane, Frank Vari, Mark Hertzberg, Kim-Anh Lê Cao, Michael R Green, Erica Han, John F Seymour, Rodney J Hicks, Devinder Gill, Pauline Crooks, Clare Gould, Kimberley Jones, Lyn R Griffiths, Dipti Talaulikar, Sanjiv Jain, Josh Tobin & Maher K Gandhi. (2015) Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study. The Lancet Haematology 2:10, pages e445-e455.
Crossref
Crossref
Yaghoub Yazdani, Mousa Mohammadnia-Afrouzi, Mehdi Yousefi, Enayat Anvari, Ghasem Ghalamfarsa, Hadi Hasannia, Sanam Sadreddini & Farhad Jadidi-Niaragh. (2015) Myeloid-derived suppressor cells in B cell malignancies. Tumor Biology 36:10, pages 7339-7353.
Crossref
Crossref
Liang Wang, Hua Wang, Zhong-Jun Xia, Hui-Qiang Huang, Wen-Qi Jiang, Tong-Yu Lin & Yue Lu. (2015) Peripheral blood lymphocyte to monocyte ratio identifies high-risk adult patients with sporadic Burkitt lymphoma. Annals of Hematology 94:10, pages 1645-1654.
Crossref
Crossref
Yu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, Tung-Ying Chao, Chia-Cheng Tseng, Wen-Feng Fang, Chin-Chou Wang, Yu-Hsiu Chung, Yi-Hsi Wang, Mao-Chang Su, Kuo-Tung Huang, Hung-Chen Chen, Ya-Chun Chang & Meng-Chih Lin. (2015) Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. PLOS ONE 10:8, pages e0136252.
Crossref
Crossref
Liang Wang, Wen Long, Peng-fei Li, Yong-bin Lin & Ying Liang. (2015) An Elevated Peripheral Blood Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Primary Pulmonary Lymphoepithelioma-Like Carcinoma. PLOS ONE 10:5, pages e0126269.
Crossref
Crossref
László Szerafin, János Jakó & Ferenc Riskó. (2015) Prognostic value of absolute monocyte count in chronic lymphocytic leukaemia. Orvosi Hetilap 156:15, pages 592-597.
Crossref
Crossref
Emmanuel Bachy & Gilles Salles. (2015) Treatment Approach to Newly Diagnosed Diffuse Large B-Cell Lymphoma. Seminars in Hematology 52:2, pages 107-118.
Crossref
Crossref
Wan Kyu Eo. (2015) Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer. World Journal of Gastroenterology 21:9, pages 2668.
Crossref
Crossref
Jay A. Read, Jean L. Koff, Loretta J. Nastoupil, Jessica N. Williams, Jonathon B. Cohen & Christopher R. Flowers. (2014) Evaluating Cell-of-Origin Subtype Methods for Predicting Diffuse Large B-Cell Lymphoma Survival: A Meta-Analysis of Gene Expression Profiling and Immunohistochemistry Algorithms. Clinical Lymphoma Myeloma and Leukemia 14:6, pages 460-467.e2.
Crossref
Crossref
R. Vaidya & T.E. Witzig. (2014) Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. Annals of Oncology 25:11, pages 2124-2133.
Crossref
Crossref
Pingping Hu, Hongchang Shen, Guanghui Wang, Ping Zhang, Qi Liu & Jiajun Du. (2014) Prognostic Significance of Systemic Inflammation-Based Lymphocyte- Monocyte Ratio in Patients with Lung Cancer: Based on a Large Cohort Study. PLoS ONE 9:10, pages e108062.
Crossref
Crossref
Xiaolei Wei, Fen Huang, Yongqiang Wei, Hui Jing, Muchen Xie, Xiaoxiao Hao & Ru Feng. (2014) Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma. Leukemia Research 38:6, pages 694-698.
Crossref
Crossref
Yan-Li Li, Yue-Yin Pan, Yang Jiao, Jie Ning, Yin-Guang Fan & Zhi-Min Zhai. (2013) Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens. Annals of Hematology 93:4, pages 617-626.
Crossref
Crossref
George J. Weiner. 2014. Advances in Tumor Immunology and Immunotherapy. Advances in Tumor Immunology and Immunotherapy
57
66
.
Rajendra Gharbaran, Andre Goy, Takemi Tanaka, Jongwhan Park, Chris Kim, Nafis Hasan, Swathi Vemulapalli, Sreeja Sarojini, Madalina Tuluc, Kip Nalley, Pritish Bhattacharyya, Andrew Pecora & K Stephen Suh. (2013) Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients. Journal of Hematology & Oncology 6:1.
Crossref
Crossref
Kathrin Aprile von Hohenstaufen, Annarita Conconi, Cassio Polpo de Campos, Silvia Franceschetti, Francesco Bertoni, Gloria Margiotta Casaluci, Anastasios Stathis, Michele Ghielmini, Georg Stussi, Franco Cavalli, Gianluca Gaidano & Emanuele Zucca. (2013) Prognostic impact of monocyte count at presentation in mantle cell lymphoma. British Journal of Haematology 162:4, pages 465-473.
Crossref
Crossref
M M Patnaik, E Padron, R R LaBorde, T L Lasho, C M Finke, C A Hanson, J M Hodnefield, R A Knudson, R P Ketterling, A Al-kali, A Pardanani, N A Ali, R S Komroji & A Tefferi. (2013) Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia 27:7, pages 1504-1510.
Crossref
Crossref
Alessia Bari, Tamar Tadmor, Stefano Sacchi, Luigi Marcheselli, Eliana Valentina Liardo, Samantha Pozzi, Stefano Luminari, Luca Baldini, Sandra Marmiroli, Massimo Federico & Aaron Polliack. (2013) Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas. Leukemia Research 37:6, pages 619-623.
Crossref
Crossref
L F Porrata, K M Ristow, T M Habermann, W R Macon, T E Witzig, J P Colgan, D J Inwards, S M Ansell, I N Micallef, P B Johnston, G Nowakowski, C A Thompson & S N Markovic. (2013) Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma. Blood Cancer Journal 3:4, pages e110-e110.
Crossref
Crossref
Nicolas Batty, Elham Ghonimi, Lei Feng, Luis Fayad, Anas Younes, Maria Alma Rodriguez, Jorge Enrique Romaguera, Peter McLaughlin, Felipe Samaniego, Larry W. Kwak & Fredrick B. HagemeisterJrJr. (2013) The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP. Clinical Lymphoma Myeloma and Leukemia 13:1, pages 15-18.
Crossref
Crossref
Su-Jin ShinJin RohMisung KimMin Jung JungYoung Wha KohChan-Sik ParkDok Hyun YoonCheolwon SuhChan-Jeong ParkHyun Sook ChiJooryung Huh. (2013) Prognostic Significance of Absolute Lymphocyte Count/Absolute Monocyte Count Ratio at Diagnosis in Patients with Multiple Myeloma. Korean Journal of Pathology 47:6, pages 526.
Crossref
Crossref